23. Symposium of the AGNP

Abstracts (HTML) List of Authors

Gaebel, W.

A longitudinal multi-center fMRI study of cognition and emotion in first-episode schizophrenia patients
Alcohol-craving: Therapeutic effects using fMRI

Gaertner, I.

TDM of psychoactive medication in the risk patient
Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Gallhofer, B.

Elementary cognitive subprocesses in a double-blind study of haloperidol and risperidone in subchronic schizophrenic patients
Reaction time decomposition and 1-back working memory tasks in drug naive and neuroleptically treated schizophrenic first-onset patients and healthy controls
Subjective reactions to neuroleptic treatment: Prediction of compliance?
Multiple T-mazes in the analysis of visuo-motor interactions in schizophrenia

Gallinat, J.

EEG source localization during postictal delirium following electroconvulsive therapy
Nerve growth factor (NGF) serum concentrations in healthy human volunteers: Physiological variance and stability
Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing
Kinematical analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer's dementia*

Galwas, C.

The course of psychiatric comorbidity in chronic alcoholics and its impact on abstinence during 4-year follow-up of integrated outpatient treatment

Gamma, A.

A longitudinal syndrome-oriented approach to phenotypic heterogeneity

Garziella, M.

New scales for measuremant of anxiety in a study with hydroxyzine for patients with generalized anxiety disorder (GAS)

Gastpar, M.

Gabapentin as a mood stabiliser in the treatment of alcoholism-SAD-comorbidity

Gattaz, W. F.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia
Abnormal phospholipid metabolism in Alzheimer's disease: 31P-spectroscopy study of the pre-frontal cortex
Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment
Phospholipase a2 activity in rat embryonic brain and in primary cultures of cortical neurons
Phospholipase A2 inhibition in the rat hippocampus disrupts short- and long-term memory processing

Gebhardt, S.

Genetic aspects of antipsychotic induced body weight change

Genius, J. J. K.

Association of cerebrovascular disease with inflammatory polymorphisms with special reference to cerebral microangiopathy

Gerlach, M.

Presentation of the AGNP-TDM expert group consensus guideline on „Therapeutic Monitoring of Psychotropic Drugs“

Gerok-Falke, K.

A new concept for crisis management in borderline patients

Gertz, H. J.

Pharmacotherapeutic options in vascular dementia

Gescher, D.

Megestrol attenuates hormonal response to CCK-4

Gesierich, T.

Effective connectivity and pharmacological modulation in schizophrenia

Geyer, M. A.

Deficient information processing and dysfunctional cognitions in unmedicated panic disorder patients

Giegling, I.

A functional SNP (V158M) in the COMT gene is associated with aggressive personality traits
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments
An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia
Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis
Systematic screen of serotonergic genes in suicidal behaviour
Association study of SNPs in G72 and DAAO in schizophrenia
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene
cDNA arrays analyses in an animal model for psychosis-related traits
Association study between the mitochondrial citrate transporter gene, a positional candidate on chromosome 22q, and schizophrenia

Giesler, M.

Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression
Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results

Gilg, T.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Gilling, K.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Gimpl, G.

Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor

Gjedde, A.

Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Glatz, D.

Altered expression of tau exon 10, clk2 and htra2-ß in post mortem brain of patients with Alzheimer’s disease

Göbel, C.

Effects of sertraline on kinematical aspects of hand movements in patients with obsessive-compulsive disorder*

Godemann, F.

Negative symptoms of schizophrenia are improved by the addition of paroxetine to neuroleptics: A double-blind placebo-controlled study

Göder, R.

Sleep-EEG in patients with schizophrenia: Analysis of power spectra and dimensional complexity
Lithium treatment for relapse prevention after electroconvulsive therapy in a patient with major depressive disorder and end stage renal disease
Modulation of sleep: A new approach of treating memory impairment in schizophrenia?

Goedecken, B.

Megestrol attenuates hormonal response to CCK-4

Goldman, D.

Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing

Gonnermann, C.

An Interleukin-1 receptor antagonist gene polymorphism and a haplotype of the Interleukin-1 gene complex may be associated with schizophrenia

Gouzoulis-Mayfrank, E.

Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies
Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users

Grauer, M. T.

Lipidperoxidation of brain homogenate and the non-enzymatic antioxidants vitamin C and vitamin E in abcb1ab (-/-) mutants and FVB controls
Results of routine CSF analysis of 1000 psychiatric patients

Graz, C.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline

Grecksch, G.

Kindling alters rewarding effects of ethanol, morphine and cocaine

Greetfeld, M.

Analysis of stress-induced CRH, CRHR1, AVP and mineralocorticoid receptor (MR) mRNA expression in C57/Bl6 mice: Implications for HPA-system regulation

Grimm, C.

Genetic variants influencing retinal degeneration and neuroprotection in the eye

Grodd, W.

Pharmako-FMRT in Alzheimers dementia

Grohmann, R.

Severe adverse drug reactions of antidepressants: Results of the German Multicenter Drug Surveillance Program AMSP
Severe adverse drug reactions of typical and atypical neuroleptics in routine clinical treatment: results from the AMSP drug safety program

Groß, W.

Predicting successful job performance of schizophrenics after discharge from hospital

Gruesser, S. M.

Relapse and gender specific activation of the striatum in alcohol dependent patients

Gründer, G.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Effects of alcohol and benzodiazepines on brain metabolism: [18F]FDG-PET studies
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography
Therapeutic drug monitoring of ziprasidone

Grunewald, R. W.

Circulating big endothelin-1 is disproportionately elevated in obstructive sleep apnea

Grunze, H.

EEG abnormalities associated with antidepressant treatment: A comparison of mirtazapine, citalopram, venlafaxine, reboxetine and amitriptyline
Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis
Treatment of bipolar depression

Gruppe, H.

Subjective reactions to neuroleptic treatment: Prediction of compliance?

Guan, Z.

Cortisol-reducing properties of quetiapine in healthy subjects under an undisturbed and an acoustic stress condition
Quetiapine improves sleep quality in healthy subjects